186044 RESULTS

Outcomes, Outcomes: Cognition is Crux of New Alzheimer’s Trials

CONFERENCE COVERAGE 2015-11-24 Conference Coverage As more drugs are entering the trials pipeline in ever-earlier-stage patients, the question of how to measure success is coming to the fore. The conventional model of measuring efficacy with dual cognitive and clinical scales such as ...

Clinical Trials on Alzheimer’s Disease 2015

CONFERENCE COVERAGE SERIES Gantenerumab, Aducanumab: Bobbing Up and Down While Navigating Currents of Trial Design Outcomes, Outcomes: Cognition is Crux of New Alzheimer’s Trials At the 8th Clinical Trials on Alzheimer’s conference held November 5-7 in Barcelona, 900 attendees ...

Postdoctoral Fellow- Innate Immunity and Neurodegeneration

JOB 2015-11-24 Employer Brigham and Women's Hospital / Harvard Medical School Principal Investigator Philip De Jager Contact Description A postdoctoral fellow position is available to support a recently funded project to explore the role of ...

Nitin Saksena on Do Sleeper Viruses Awaken in ALS?

COMMENT Even though I like the study, which is solid and agreeable in part, I have some philosophical points to make that may help unveil more concrete associations between ERV and human disease. I believe that it is too early to conclude that HERV-K expression ...

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From